Many patients with heart failure take Digoxin to improve their heart function. One medication, Digitek, whose main ingredient is Digoxin, is produced in New Jersey by Activis, and marketed as “Bertek” or “UDL”. It is being recalled because of improper dosage in the active ingredient, Digoxin, and it may contain twice the appropriate amount of Digoxin.
Activis has advised that: “Tablets with double the appropriate thickness may have been commercially released. These tablets may contain twice the approved level of active ingredient than is appropriate,”
Patients taking the double-strength pills are at risk for digitalis toxicity, characterized by such symptoms as nausea vomiting, low blood pressure and, possibly, death. Patients taking Digitek should contact their physician immediately for medical advice, and pharmacies selling Digitek should return the product to the place of purchase.